Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18480742 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10
Condition: Sarcoma, Synovial
Interventions: Drug: OTSA101-DTPA-90Y level 1;   Drug: OTSA101-DTPA-90Y level 2;   Drug: OTSA101-DTPA-90Y level 3

Indicates status has not been verified in more than two years